NasdaqGM - Delayed Quote USD
Harmony Biosciences Holdings, Inc. (HRMY)
29.61
+0.18
+(0.61%)
At close: April 25 at 4:00:02 PM EDT
29.61
0.00
(0.00%)
After hours: April 25 at 4:05:13 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BUDUR KUMAR Officer | Conversion of Exercise of derivative security | Jan 24, 2025 | 1,036 |
| DAYNO JEFFREY M Chief Executive Officer | Conversion of Exercise of derivative security | Jan 24, 2025 | 5,933 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security | Mar 3, 2025 | 0 |
| KAPADIA SANDIP S. Chief Financial Officer | Sale | Apr 1, 2025 | 0 |
| MARSHMAN FUND TRUST II Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 5, 2024 | 6,051,120 |
| SERAFIN ANDREW Officer | Conversion of Exercise of derivative security | Jan 24, 2025 | 1,635 |
| VALOR IV PHARMA HOLDINGS L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Nov 5, 2024 | 6,618,030 |
Related Tickers
JAZZ Jazz Pharmaceuticals plc
110.80
+1.67%
CPRX Catalyst Pharmaceuticals, Inc.
23.45
+1.12%
PTGX Protagonist Therapeutics, Inc.
44.49
-0.80%
REPL Replimune Group, Inc.
9.05
-0.11%
HALO Halozyme Therapeutics, Inc.
60.49
+2.09%
MIRM Mirum Pharmaceuticals, Inc.
40.80
+0.82%
GMAB Genmab A/S
20.59
+0.24%
FOLD Amicus Therapeutics, Inc.
7.35
+2.08%
MLYS Mineralys Therapeutics, Inc.
13.34
-5.32%
LEGN Legend Biotech Corporation
34.28
+0.12%